IFG
GSK icon

Independent Financial Group’s GSK GSK Stock Holding History

Independent Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Sell
5,973
-472
-7% -$25K 0.01% 1216
2026
Q1 		$356K Sell
6,445
-955
-13% -$51.8K 0.01% 1081
2025
Q4 		$363K Sell
7,400
-52
-0.7% -$2.42K 0.01% 1054
2025
Q3 		$322K Buy
7,452
+10
+0.1% +$391 0.01% 1057
2025
Q2 		$286K Buy
7,442
+28
+0.4% +$1.07K 0.01% 1054
2025
Q1 		$287K Buy
7,414
+30
+0.4% +$1.1K 0.01% 950
2024
Q4 		$250K Sell
7,384
-908
-11% -$32.7K 0.01% 972
2024
Q3 		$339K Buy
8,292
+136
+2% +$5.56K 0.01% 825
2024
Q2 		$314K Sell
8,156
-308
-4% -$13K 0.01% 810
2024
Q1 		$363K Buy
8,464
+6
+0.1% +$247 0.02% 707
2023
Q4 		$313K Buy
8,458
+760
+10% +$27.3K 0.02% 705
2023
Q3 		$279K Buy
7,698
+1,640
+27% +$58.2K 0.02% 685
2023
Q2 		$216K Hold
6,058
– – 0.01% 792
2023
Q1 		$216K Sell
6,058
-990
-14% -$34.6K 0.02% 746
2022
Q4 		$248K Buy
7,048
+250
+4% +$8.33K 0.02% 635
2022
Q3 		$200K Sell
6,798
-2,380
-26% -$90.2K 0.02% 673
2022
Q2 		$499K Buy
9,178
+3,080
+51% +$170K 0.05% 387
2022
Q1 		$332K Buy
6,098
+360
+6% +$19.6K 0.03% 559
2021
Q4 		$316K Buy
5,738
+520
+10% +$27.1K 0.03% 574
2021
Q3 		$249K Buy
+5,218
New +$262K 0.03% 594

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Independent Financial Group's GSK Position: Q2 2026 in Review

Independent Financial Group reduced its GSK (GSK) stake by 7.3% in Q2 2026, selling an estimated $25K and leaving 5,973 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #1216.

Independent Financial Group first reported a position in GSK in Q3 2021 and has held it in 20 quarters since. The position peaked at $499K in Q2 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Independent Financial Group held 5,973 shares of GSK worth $313K as of Q2 2026.
  • Independent Financial Group sold 472 GSK shares in Q2 2026, an estimated $25K.
  • GSK made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #1216 holding.
  • Independent Financial Group first reported a position in GSK in Q3 2021 and has held it in 20 quarters since.
  • Independent Financial Group's GSK position peaked at $499K in Q2 2022.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.